AC Immune Ltd (ACIU) Event Aug. 02, 2022, 15:12 UTC 14 1 comments (90% Positive) AC Immune Ltd (ACIU) Announces Clinical Development Update (Form 6-K) Comment Full text
Gilead Sciences Inc (GILD) Event Aug. 02, 2022, 13:03 UTC 99 0 comments Gilead - Q2 2022 Presentation Comment Full text
C4 Therapeutics Inc (CCCC) Event Aug. 02, 2022, 12:33 UTC 17 1 comments (90% Positive) C4 THERAPEUTICS, INC. (CCCC) Provides Update on Development for Support of Successful Product Launches – –Dr Comment Full text
Rallybio Corporation (RLYB) Event Aug. 02, 2022, 12:30 UTC 17 1 comments (50% Neutral) RALLYBIO CORPORATION (RLYB) Announces Clinical Development Update Comment Full text
Evolus Inc (EOLS) Event Aug. 02, 2022, 12:29 UTC 17 1 comments (30% Negative) EVOLUS, INC. (EOLS) Reports Q3 2022 Financial Results Comment Full text
Phathom Pharmaceuticals Inc (PHAT) Event Aug. 02, 2022, 12:25 UTC 17 1 comments (19% Negative) PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports Q3 2022 Financial Results Comment Full text
Blueprint Medicines Corp (BPMC) Event Aug. 02, 2022, 11:47 UTC 17 1 comments (10% Negative) Blueprint Medicines Corporation (BPMC) Reports Q3 2022 Financial Results Comment Full text
Harmony Biosciences (HRMY) Event Aug. 02, 2022, 11:45 UTC 17 1 comments (10% Negative) HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) Reports Q3 2022 Financial Results Comment Full text
Incyte Corporation (INCY) Event Aug. 02, 2022, 11:25 UTC 17 1 comments (30% Negative) INCYTE CORPORATION (INCY) Reports Q3 2022 Financial Results Comment Full text
Esperion Therapeutics Inc (ESPR) Event Aug. 02, 2022, 11:24 UTC 17 1 comments (30% Negative) Esperion Therapeutics, Inc. (ESPR) Reports Q3 2022 Financial Results Comment Full text